Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has conducted a risk assessment on the potential impact of (a) future pandemics and (b) geopolitical disruption to the UK's blood stocks; and what contingency plans are in place for these scenarios.

There are four blood services within the United Kingdom, namely the Welsh Blood Service, the Scottish National Blood Transfusion Service, the Northern Ireland Blood Service, and NHS Blood and Transplant (NHSBT). In England, NHSBT moves blood around the country to balance blood stocks in all areas, and works closely with the other UK blood services.

The risks and impacts posed by pandemic disease is closely monitored by NHSBT through a risk assessment and a pandemic disease contingency plan. NHSBT is largely self-sufficient in the supply of whole blood to hospitals in England, and isn't reliant on supplies from other countries. Beyond its ability to move blood stocks to where they are needed across the country, NHSBT mitigates geopolitical risks to blood stocks through commercial arrangements with suppliers of vital consumables from overseas, for instance by sourcing blood bags from multiple supply regions and flexing stock holdings.